A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists ...

It was found that those with severe hemophilia B have less than 1% of normal factor IX activity, often experiencing spontaneous bleeding that can cause joint damage or life-threatening events.

In a 13-year follow-up by St. Jude Children’s Research Hospital and University College London published in The New England ...

A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists from St. Jude Children's ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

There is a need to raise awareness among the public about genetic disorders such as thalassemia, sickle cell anemia and hemophilia, all of which require continuous medication, said Minister for ...

Hemophilia A Market Trends The report provides a detailed analysis of the current hemophilia A marketed drugs and late-stage pipeline drugs ...

Hemophilia A is either congenital, i.e., genetic; or the coagulation disorder is acquired, i.e., it develops over the course of a lifetime. In the first case, those affected lack coagulation ...

Roughly 55 people on Guam are diagnosed with a bleeding disorder, but as the National Bleeding Disorder Foundation stressed, ...

The results mark a significant step forward in developing treatments for rare diseases, especially in low-resource settings. UNDERSTANDING HEMOPHILIA A Hemophilia A is a rare genetic disorder ...